These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38797152)
21. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease. Romualdo GR; Da Silva TC; de Albuquerque Landi MF; Morais JÁ; Barbisan LF; Vinken M; Oliveira CP; Cogliati B Environ Toxicol; 2021 Feb; 36(2):168-176. PubMed ID: 32918399 [TBL] [Abstract][Full Text] [Related]
22. Oxymatrine alleviates high-fat diet/streptozotocin-induced non-alcoholic fatty liver disease in C57BL/6 J mice by modulating oxidative stress, inflammation and fibrosis. Lou D; Fang Q; He Y; Ma R; Wang X; Li H; Qi M Biomed Pharmacother; 2024 May; 174():116491. PubMed ID: 38537582 [TBL] [Abstract][Full Text] [Related]
23. Roflumilast Ameliorates Airway Hyperresponsiveness Caused by Diet-Induced Obesity in a Murine Model. Park HJ; Lee JH; Park YH; Han H; Sim da W; Park KH; Park JW Am J Respir Cell Mol Biol; 2016 Jul; 55(1):82-91. PubMed ID: 26756251 [TBL] [Abstract][Full Text] [Related]
24. Long-term profile of serological biomarkers, hepatic inflammation, and fibrosis in a mouse model of non-alcoholic fatty liver disease. Toita R; Kang JH Toxicol Lett; 2020 Oct; 332():1-6. PubMed ID: 32579995 [TBL] [Abstract][Full Text] [Related]
25. Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model. Heo YJ; Choi SE; Lee N; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ J Gastroenterol Hepatol; 2021 Sep; 36(9):2592-2600. PubMed ID: 33600604 [TBL] [Abstract][Full Text] [Related]
26. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor. Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475 [TBL] [Abstract][Full Text] [Related]
27. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling. He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523 [TBL] [Abstract][Full Text] [Related]
28. 1,2,3,4,6 penta-O-galloyl-β-D-glucose ameliorates high-fat diet-induced nonalcoholic fatty liver disease and maintains the expression of genes involved in lipid homeostasis in mice. Kant R; Lu CK; Nguyen HM; Hsiao HH; Chen CJ; Hsiao HP; Lin KJ; Fang CC; Yen CH Biomed Pharmacother; 2020 Sep; 129():110348. PubMed ID: 32554245 [TBL] [Abstract][Full Text] [Related]
29. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation. Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620 [TBL] [Abstract][Full Text] [Related]
30. Pea Albumin Extracted from Pea ( Zhang S; Cui Z; Zhang H; Wang P; Wang F; Zhang J Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064674 [TBL] [Abstract][Full Text] [Related]
31. The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice. Li X; Wang Z; Klaunig JE Toxicology; 2019 Mar; 416():1-14. PubMed ID: 30711707 [TBL] [Abstract][Full Text] [Related]
32. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats. Ma Z; Chu L; Liu H; Wang W; Li J; Yao W; Yi J; Gao Y Sci Rep; 2017 Mar; 7():44819. PubMed ID: 28300221 [TBL] [Abstract][Full Text] [Related]
33. Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice. Xue H; Chen D; Zhong YK; Zhou ZD; Fang SX; Li MY; Guo C Ann N Y Acad Sci; 2016 Jul; 1375(1):52-65. PubMed ID: 27447538 [TBL] [Abstract][Full Text] [Related]
34. A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway. Xie Y; Jin Y; Wen J; Li G; Huai X; Duan Y; Ni F; Fu J; Li M; Li L; Yan M; Cao L; Xiao W; Yang H; Wang ZZ Biomed Pharmacother; 2024 Jul; 176():116908. PubMed ID: 38850668 [TBL] [Abstract][Full Text] [Related]
35. Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis. Shih PH; Shiue SJ; Chen CN; Cheng SW; Lin HY; Wu LW; Wu MS Mar Drugs; 2021 Mar; 19(3):. PubMed ID: 33809062 [TBL] [Abstract][Full Text] [Related]
36. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice. Yang F; Huang P; Shi L; Liu F; Tang A; Xu S Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293 [TBL] [Abstract][Full Text] [Related]
37. Protective Effects of Gnetin C from Melinjo Seed Extract against High-Fat Diet-Induced Hepatic Steatosis and Liver Fibrosis in NAFLD Mice Model. Kabir T; Yoshiba H; Agista AZ; Sultana H; Ohsaki Y; Yeh CL; Hirakawa R; Tani H; Ikuta T; Nochi T; Yang SC; Shirakawa H Nutrients; 2023 Sep; 15(18):. PubMed ID: 37764672 [TBL] [Abstract][Full Text] [Related]
38. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice. Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834 [TBL] [Abstract][Full Text] [Related]
40. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study. Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]